Galapagos (GLPG)
(Delayed Data from NSDQ)
$28.65 USD
-0.11 (-0.38%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $28.66 +0.01 (0.03%) 7:22 PM ET
3-Hold of 5 3
D Value F Growth A Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
GLPG 28.65 -0.11(-0.38%)
Will GLPG be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for GLPG based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GLPG
Down -9.97% in 4 Weeks, Here's Why You Should You Buy the Dip in Galapagos (GLPG)
Bristol Myers (BMY) Reports Positive Colorectal Cancer Study Data
GLPG: What are Zacks experts saying now?
Zacks Private Portfolio Services
Fate Therapeutics (FATE) Surges 86.4% YTD on Pipeline Progress
Amylyx (AMLX) Withdraws ALS Drug, Cuts Workforce by 70%
After Plunging -7.94% in 4 Weeks, Here's Why the Trend Might Reverse for Galapagos (GLPG)
Other News for GLPG
Galapagos NV Unveils CAR-T Therapy Advances
Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024
Galapagos announces clinical/ translational data on hematological cancer care
Crocs initiated, Bill downgraded: Wall Street's top analyst calls
Galapagos just downgraded at BofA, here's why